Review
. 1998 Jul;51(1 Suppl 1):S36-44; discussion S65-7.
doi: 10.1212/wnl.51.1_suppl_1.s36.
Pharmacologic treatment of cognition in Alzheimer's dementia
Affiliations
- PMID: 9674761
- DOI: 10.1212/wnl.51.1_suppl_1.s36
Item in Clipboard
Review
Pharmacologic treatment of cognition in Alzheimer's dementia
Neurology.
1998 Jul.
Abstract
Much of the treatment research and development for Alzheimer's disease (AD) in recent years has been based on the cholinergic hypothesis. Cholinesterase inhibition has been shown to improve the symptoms of mild to moderate AD. Two cholinesterase inhibitors (CIs) are now available and two more may be available shortly. Free radical inhibitors, estrogen, and anti-inflammatory drugs may also delay the onset and slow progression of AD. Combination therapies employing CIs and these other drugs may prove successful in the future.
Similar articles
-
Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs.J Neural Transm Suppl. 1998;53:255-75. doi: 10.1007/978-3-7091-6467-9_23. J Neural Transm Suppl. 1998. PMID: 9700663 Review.
-
Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.J Alzheimers Dis. 2015;48(4):1033-41. doi: 10.3233/JAD-150092. J Alzheimers Dis. 2015. PMID: 26444756
-
Cholinesterase inhibitors as Alzheimer's therapeutics (Review).Mol Med Rep. 2019 Aug;20(2):1479-1487. doi: 10.3892/mmr.2019.10374. Epub 2019 Jun 11. Mol Med Rep. 2019. PMID: 31257471 Free PMC article. Review.
-
Drugs influencing cognitive function.Indian J Physiol Pharmacol. 1994 Oct;38(4):241-51. Indian J Physiol Pharmacol. 1994. PMID: 7883287 Review. No abstract available.
-
Cognitive enhancement therapy for Alzheimer's disease. The way forward.Drugs. 1997 May;53(5):752-68. doi: 10.2165/00003495-199753050-00003. Drugs. 1997. PMID: 9129864 Review.
Cited by
-
Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial.J Neurol Neurosurg Psychiatry. 2001 Nov;71(5):589-95. doi: 10.1136/jnnp.71.5.589. J Neurol Neurosurg Psychiatry. 2001. PMID: 11606667 Free PMC article. Clinical Trial.
-
Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS.Pharmacol Res. 2010 Jan;61(1):14-26. doi: 10.1016/j.phrs.2009.10.002. Epub 2009 Oct 17. Pharmacol Res. 2010. PMID: 19840853 Free PMC article. Review.
-
Radiopharmaceuticals for positron emission tomography investigations of Alzheimer's disease.Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1575-93. doi: 10.1007/s00259-009-1301-z. Epub 2009 Dec 22. Eur J Nucl Med Mol Imaging. 2010. PMID: 20033156 Review.
-
Pharmacokinetic Evaluation of a Novel Donepezil-Loaded Dissolving Microneedle Patch in Rats.Pharmaceutics. 2021 Dec 21;14(1):5. doi: 10.3390/pharmaceutics14010005. Pharmaceutics. 2021. PMID: 35056902 Free PMC article.
-
Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimen.Int J Clin Pract. 2006 May;60(5):533-40. doi: 10.1111/j.1368-5031.2006.00892.x. Int J Clin Pract. 2006. PMID: 16700849 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
